Editas MedicineEDIT

那斯達克 · USD
2.05
+0.03
(+1.49%)
盤中 01/21 10:39 (UTC+8)
01/21 10:39 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.03
  • 0.05
  • 0.60
  • 0.01
  • 0.01
  • 0.00
  • 0.31
  • 0.05
  • 0.04
  • 0.08
icon
  • -70.69
  • 84.83
  • 1025.36
  • -98.11
  • -54.71
  • -88.13
  • 50070.49
  • -84.78
  • -23.19
  • 110.82
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
7,543
3,578
4,658
30,604
61
514
1,135
60,049
5,336
2,887
營業成本
----------
營業毛利
7,543
3,578
4,658
30,604
61
514
1,135
60,049
5,336
2,887
營業費用
32,09155,122-77,197---84,01155,49946,982
研發費用
19,77516,18126,59348,61147,63954,21048,78769,55640,51229,779
推銷及管理費用
12,31612,85913,37516,35418,08818,20619,33914,45514,98717,203
非經常性項目費用
-26,08240,85312,232------
其他營業費用
----------
營業利益
-24,548
-51,544
-76,163
-46,593
-65,666
-71,902
-66,991
-23,962
-50,163
-44,095
其他收入及費用
1,8303292,2911,1983,5254,2955,0415,0885,1443,805
利息費用
2,3992,0202,216-------
稅前純益
-25,117
-53,235
-76,088
-45,395
-62,141
-67,607
-61,950
-18,874
-45,019
-40,290
所得稅
----------
稅後純益
-25,117
-53,235
-76,088
-45,395
-62,141
-67,607
-61,950
-18,874
-45,019
-40,290
基本每股稅後盈餘(元)
-0.28-0.63-0.92-0.55-0.75-0.82-0.76-0.23-0.55-0.56
稀釋每股稅後盈餘(元)
-0.26-0.62-0.92-0.55-0.75-0.82-0.76-0.21-0.54-0.56
基本平均股數(千股)
90090.0084412.0083055.0082613.0082485.0082310.0081938.0081710.0081648.0071376.00
稀釋平均股數(千股)
90090.0084412.0083055.0082613.0082485.0082310.0081938.0081710.0081648.0071376.00
還原基本每股稅後盈餘(元)
-0.28-0.63-0.92-0.55-0.75-0.82-0.76-0.23-0.55-0.56
還原稀釋每股稅後盈餘(元)
-0.26-0.62-0.92-0.55-0.75-0.82-0.76-0.21-0.54-0.56
還原基本平均股數(千股)
90,09084,41283,05582,61382,48582,31081,93881,71081,64871,376
還原稀釋平均股數(千股)
90,09084,41283,05582,61382,48582,31081,93881,71081,64871,376
EBITDA(千元)
-22,059-49,638-72,538-44,883-61,868-68,067-62,257-19,511-44,752-38,057

大家都在看

HOT